Mr Geoffrey Franglen (Department ofChemicalPathology, St George's Hospital Medical School, London) The Role ofPlasma Albumin and its Relation to its Structure [Abridged] Two aspects of plasma albumin can usefully be ccnsidered in the context of this symposium, its mode of catabolism and its ability to combine reversibly with many different compounds. Albumin is one of the more stable plasma proteins but it can be broken down rapidly and used as a source of amino acids when needed. What change takes place in the molecule to allow this to happen? How may this be taken into account when preparing albumin for clinical use? Albumin is highly efficient as a transport protein. Proteins often have reactive sites for particular compounds and may also combine unspecifically with other materials. Albumin is peculiar in that, while it does not appear to combine specifically with anything, it does combine reversibly with a wide range of materials. In many cases this would appear to be a genuine property and not solely due to its high concentration in the plasma. How does this one protein provide a surface which can react with so many different compounds?
The best estimate for the molecular weight of human plasma monomer albumin is about 66,000 d. There appears to be no structural lipid nor carbohydrate and the molecule contains about 610 amino acids. End group analysis shows that only one of these is N-terminal, only one is C-terminal and that there are no masked end groups. These six hundred amino acids are thus linked together as a single polypeptide chain. This is not random in form but is structured by two distinct processes. Firstly, about half of it is coiled into a right-handed a-helix (Callaghan & Martin 1962) . Secondly, more rigorous stabilization is effected by the presence of 17 disulphide bonds between the cysteine residues. These bonds fall into three groups with distinctly different strengths (Franglen & McArdle, in preparation). Ten can be reduced easily, the next four with more difficulty and the last few with considerable difficulty (Fig 1) . This suggests that the ten bonds of the first group connect widely different parts of the molecule and are thus important for the maintenance of overall structure, whilst the remainder connect areas much closer together.
Albumin expands when the pH is brought below 4-5. Harrington et al. (1956) concluded from this that the molecule was arranged in the form of two globular units joined by a short section of the polypeptide chain. On closer examination, however, this expansion was found to take place in two stages. From this, together with other data, Foster (1960) proposed a four part structure for albumin ( Fig 2) . According to this hypothesis these four parts are folded together in the shape of a single globule at neutral pH. When the pH is lowered the Harrington units part about a central hinge. These each open up to reveal another two units when the pH is lowered further still. At low pH, therefore, albumin should consist of four globular units joined only by short, flexible pieces of the polypeptide chain.
When a protein molecule is opened up in this way the exposed hinges will be more susceptible to proteolysis than the rest of the molecule. Weber & Young (1964) accordingly expanded albumin by lowering the pH and followed this by a brief Section ofExperimental Medicine and Therapeutics 1073 hydrolysis with weak pepsin. They found that it broke up into a small number of separable pieces the sizes of which fitted fairly well with Foster's model. We have carried out a similar experiment recently and have examined the fragments so obtained for molecular weight, antibody activity, amino acid composition and, in particular, the distribution of disulphide bonds (Franglen & Swaniker, in preparation) . The results confirm the general hypothesis that albumin expands and may be hydrolysed at specific points under these conditions, but, in detail they do not support Foster's hypothesis of a four globular unit structure. We propose instead that the albumin molecule consists of a highly structured core to which are attached one or two flexible 'tails' (Fig 3) . One fragment of molecular weight 34,000 d forms the main core of the molecule and is structured by ten disulphide bonds. This core is flanked on one side by a slightly smaller fragment (molecular weight of 29,000 d) which probably considerably overlaps it and which contains six disulphide bonds. It is flanked on the other side by a single sequence of 120-130 amino acids which contain no disulphide bonds. Such a section will be highly flexible and stabilized primarily by a-helices. There is a fourth fragment which must also be flexible since it contains only one disulphide bond whilst making up about a quarter of the molecule. So far it is not possible to assign a position to this fragment. It may be a continuation of the flexible tail attached to the core, in which case albumin would consist of a heavily structured core to which is attached a single, long, less structured tail. Alternatively it may be attached to the other side of the central fragments, and albumin would consist of a core with two tails. Support for this model has come from the work of Luzzati et al. (1961) . In an examination of albumin by X-ray diffraction they concluded that albumin consists of two parts, 60% being highly structured and the remainder distinctly less so.
Although the tail attached to the central core has no structuring disulphide bonds, it contains an important reactive group ofalbumin, the single free sulphydryl. To a limited extent this free sulphydryl forms mixed disulphides with the plasma thiols, cysteine and glutathione. Because of this, albumin prepared from fresh plasma is usually found to contain only 0-7 moles of free sulphydryl per mole of albumin. It is also for this reason that plasma left to stand will gradually lose its free cysteine and that the albumin in that plasma will completely lose its free sulphydryl titre.
A high proportion of albumin prepared for clinical use in this country is made from outdated plasma. The observations on the incorporation of thiols into albumin may thus be of medical significance, since such incorporation appears to alter the stability of the molecule and this may be the first step in its catabolism. Cathepsins will hydrolyse albumin, but only after it has been treated with glutathione (Libenson & Jena 1964 ). Jeejeebuoy (1965) has noted that labelled Lister albumin is not suitable for survival studies since it has a half-life well below the accepted values. I have not had the opportunity of examining his samples, but in the samples of Lister AP2 and AP3 which I have examined the sulphydryl titre has always been very low or absent, suggesting that cysteine or glutathione had already been incorporated. The masking of a reactive group, such as a sulphydryl, would seem, on the face of it, more likely to increase rather than decrease the stability of a molecule. Disulphide interchange can occur, however, after the incorporation of cysteine or glutathione so that the thiol can penetrate into the molecule (Andersson 1965 ) and thus bring about alterations of its conformation. It would seem likely that this type of interchange would be confined to the less stable disulphide bonds described above.
There may be, however, during the formation of albumin in the cell genetically determined alternatives in sulphydryl pairing, involving, perhaps, the less easily broken disulphide bonds. This will be considered a form of heresy by some protein chemists since I am suggesting that, although albumin has a unique primary sequence of amino acids, there are at least two acceptable ways of pairing its cysteines into disulphide bonds. This would result in the formation of two albumins, identical in amino acid composition, electrophoretic mobility and many other properties but differing in conformation and in surface structure. A number of observations suggest this may be true. Firstly, Mackay & Maitin (1957) reported that albumin heated at 58°C at pH 6-5 breaks down into about equal parts of aggregated and un-aggregated molecules. Stokrova & Sponar (1963) separated the unaggregated albumin from such an experiment and then continued heating it at 58°C. They showed that there was no further significant production of aggregated material at that temperature. It was concluded, therefore, that this experiment distinguishes between two classes of albumins, one of which aggregates more rapidly in these conditions than the other; it is not a case of a simple equilibrium being set up between the unaggregated and the aggregated forms.
Secondly, there is bisalbuminemia, those genetically determined cases where the normal plasma albumin is replaced by two albumins. One of these runs normally on electrophoresis, whilst the other runs at a distinctly different rate due to an alteration in the primary amino acid sequence. In the seven families with this condition that I have examined all the affected sera show the same thing, the ratio of the aberrant to the normal albumin being very close to 1: 1; this has been repeatedly reported by other investigators working on other families. There are two possible hypotheses to account for this. It can be postulated that in the bisalbuminwmic there is a gene change resulting in the production of an albumin with an aberrant primary amino acid sequence. At the same time this alteration produces a completely new control which ensures that the two albumins are always made in equal amounts, even from family to unrelated family. Alternatively a more simple hypothesis can be postulated that there are normally two albumins present in plasma. These albumins have the same primary amino acid sequence and the same electrophoretic mobility, but they have slightly different conformations and their ratio is maintained at 1: 1 by a control which is normally present. In bisalbuminmemia only one of these albumins is affected in its primary amino acid sequence and thus can be distinguished from the other by electrophoresis, but the normal ratio between the two albumins is maintained unaffected. There is a curious observation which suggests that this latter hypothesis might be true. When labelled thyroxine is added to normal plasma it initially tags the albumin. Sarcione & Aungst (1962) found that with a bisalbuminemic serum the whole of the labelled thyroxine went on to the aberrant albumin, not the normal one. This is not a matter of competition since the same can be observed when the albumins are separated. The second hypothesis would explain this phenomenon quite simply, thus: thyroxine tags only one of the normal albumins, not both, and in Sarcione's case of bisalbuminmmia the amino acid sequence of the thyroxine binding albumin was affected, not the other. This microheterogeneity of albumin would be beneficial to an animal, since, as suggested by the observations on thyroxine binding, alternatives in albumin conformation would provide alternatives in surface structure. This would increase the range of reactions of a primitive albumin and thus increase the number of different materials it might transport. A similar type of evolution is already recognized in y-globulin where the range of antigenic reactions of the primitive protein has been considerably increased by replacing it with a mixture of molecules with subtle alternatives in the primary amino acid sequences of their peptide chains. It may be that in albumin a similar increase in reaction and function from the original albumin has been evolved, not through having alternatives in the primary sequence of the amino acids, but through alternatives in the conformation of the molecule.
Dr Victor M Rosenoer (Department ofMedicine, Royal Free Hospital, London)
Investigation of Albumin Metabolism in Man
Investigations of protein metabolism, before the era of isotope-labelled proteins, were based largely on nitrogen balance studies. Methods are now available which measure directly the rates of albumin catabolism and synthesis. The catabolic studies are technically far simpler and, under steady state conditions, the synthesis rate of albumin can be inferred. After "311-labelled albumin is injected intravenously, the plasma, urine, and total body 1311 activity may be measured daily and the results plotted against time. If all the 131I released by the labelled protein breakdown is completely and rapidly excreted by the kidneysand this may be ensured by the administration of 200 mg potassium iodide dailythe catabolic rate can be estimated from the urinary
